New Compounds
Abstract
The novel optically pure compounds Na + , Mg 2+ , Li + , K + , Ca 2+ and N + (R) 4 salts of (+)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole or (−)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, in particular sodium and magnesium salt form thereof, where R is an alkyl with 1-4 carbon atoms, processes for the preparation thereof and pharmaceutical preparations containing the compounds as active ingredients, as well as the use of the compounds in pharmaceutical preparations and intermediates obtained by preparing the compounds.
Claims
exact text as granted — not AI-modified1 . An optically pure enantiomeric compound comprising a Na + , Mg 2+ , Li + , K + , Ca 2+ or N + (R) 4 salt of (+)-5-methoxy-2-[[(4-methoxy-3,5,dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole or (−)-5-methoxy-2-[[(4-methoxy-3,5,dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, wherein R is an alkyl with 1-4 carbon atoms.
2 - 34 . (canceled)Join the waitlist — get patent alerts
Track US2010222591A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.